Volume 30, Issue 2 pp. 179-184
Original Article

Congenital Heart Surgery in Patients with Ventricular Noncompaction

Wen-zhou Yu M.D.

Wen-zhou Yu M.D.

Department of Cardiovascular Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, P.R. China

Department of Cardiovascular Surgery, Weifang People's Hospital, Weifang, Shandong, China

Search for more papers by this author
Ying Wang

Ying Wang

Department of Nursing, Weifang Medical College, Weifang, Shandong, China

Search for more papers by this author
Jian-wei Zheng

Jian-wei Zheng

Department of Cardiovascular Surgery, Weifang People's Hospital, Weifang, Shandong, China

Search for more papers by this author
Cheng-wei Zou M.D.

Corresponding Author

Cheng-wei Zou M.D.

Department of Cardiovascular Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, P.R. China

Address for correspondence: Cheng-wei Zou, the Department of Cardiovascular Surgery, Provincial Hospital Affiliated to Shandong Univeristy, 44#, Wenhua Xi Road, Jinan, Shandong 250021, P.R.China. fax: 86-0531-87902348; 86-0531-85186302. e-mail: [email protected]

Search for more papers by this author
First published: 18 December 2014
Citations: 4
Conflict of interest: The authors acknowledge no conflict of interest in the submission.

ABSTRACT

Background

Noncompaction of the ventricular myocardium (NVM) is exceedingly rare and associated with a high morbidity and mortality. This pathology has been associated with other congenital heart diseases (CHDs). The efficacy of surgical treatment of patients with NVM and other CHDs is largely unknown. The aim of the present study was to describe surgical outcomes of 16 patients.

Methods and Results

Between April 2009 and October 2011, 16 patients with NVM and CHD were admitted to our hospital. Through a clinical chart review, we analyzed results of surgical treatment of NVM with other CHDs retrospectively. The median age was 3.9 years (range 2 m–11 y). The follow-up time was 23.93 months (range 3 m–36 m). Two patients (12.5%) died after the surgery, the remaining patients (87.5%) had an uneventful postoperative course. An additional patient died due to sudden death three months after surgery. Two patients developed recurrent heart failure after surgery. Congestive heart failure, severe arrhythmias, and the range of NVM may be risk factors for death. At 6 months after the operation, the NYHA functional class was significantly improved (2.38 ± 0.89 vs. 1.62 ± 0.65, p = 0.009). The cardiothoracic ratio was significantly reduced when compared to before the operation (p < 0.001).

Conclusions

Surgery in patients with NVM and other CHDs can be effective in relieving heart failure, improving heart function, and decreasing heart size. doi: 10.1111/jocs.12489 (J Card Surg 2015;30:179–184)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.